- (2011-03-02)佐力药业：专注药用真菌 继续领跑
- (2011-03-01)两成次新股业绩变脸 哪些券商是绩差股幕后推手
- (2011-03-01)苏渝：打新打成大股东 喜剧还是悲剧
- (2011-02-28)曹中铭：新股发行失败情况很难出现
- (2011-02-28)警惕A股癌变：上市难道仅为原始股东盈利后脱手
- (2011-02-26)专家释疑：新股破发不是常态
- (2011-02-26)破发潮下 给投行更大自主配售权不可取
- (2011-02-25)叶檀：这两年是直接融资的大好时机
- (2011-02-25)“不败神话”破灭并非坏事
- (2011-02-24)通裕重工IPO：应收账款风险极大
- (2011-02-24)兔年新股暂别破发潮
- (2011-02-23)询价新规后首批解禁股抛压或有限
- (2011-02-23)新股回暖的背后：一级市场投资者更趋成熟
- (2011-02-22)归位市场和理性投资：新股定价合理化缺一不可
- (2011-02-22)17新股首日破发谁的错
- (2011-02-21)畸形新股发行定价绑架A股
- (2011-02-21)建立成熟的“破发观”
- (2011-02-19)五新股上市有望扫清破发阴霾
- (2011-02-19)朗源股份周二上市 机构平均目标价22.02元
- (2011-02-18)新股破发有利于完善市场化定价机制
- (2011-02-18)新股缘何在破发与大涨间蹦极
- (2011-02-17)再融资潮起 A股面临严峻考验
- (2011-02-17)破发魔咒消除 破发次新股有钱途
- (2011-02-16)“破发”迫使新股低下高昂的头
- (2011-02-16)市场转暖 新股赚钱效应重现
